{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:32Z","timestamp":1787020712573,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12958-017-0232-y","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T07:30:29Z","timestamp":1488871829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-3298","authenticated-orcid":false,"given":"Eberhard","family":"Nieschlag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marc G.","family":"Bouloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Ravi","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjela","family":"Tzontcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"McCrary Sisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann M.","family":"Behre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"issue":"Suppl 1","key":"232_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6061\/clinics\/2013(Sup01)09","volume":"68","author":"R Fraietta","year":"2013","unstructured":"Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo). 2013;68 Suppl 1:81\u20138.","journal-title":"Clinics (Sao Paulo)"},{"key":"232_CR2","doi-asserted-by":"publisher","unstructured":"Rohayem J, Zitzmann M, Nieschlag E. Congenital hypogondotropic hypogonadism and Kallmann\u2019s syndrome. Reference Module in Biomedical Sciences. Elsevier 12-Dec-15; doi: 10.1016\/B978-0-12-801238\u20133.98874\u20133 .","DOI":"10.1016\/B978-0-12-801238%E2%80%933.98874%E2%80%933"},{"key":"232_CR3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM196605122741905","volume":"274","author":"B Lytton","year":"1966","unstructured":"Lytton B, Kase N. Effects of human menopausal gonadotrophin on a eunuchoidal male. N Engl J Med. 1966;274:1061\u20134.","journal-title":"N Engl J Med"},{"key":"232_CR4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1530\/eje.0.1390298","volume":"139","author":"D Buechter","year":"1998","unstructured":"Buechter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139:298\u2013303.","journal-title":"Eur J Endocrinol"},{"key":"232_CR5","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0015-0282(16)57619-5","volume":"63","author":"S Kliesch","year":"1995","unstructured":"Kliesch S, Behre HM, Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril. 1995;63:1326\u20138.","journal-title":"Fertil Steril"},{"key":"232_CR6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/j.1939-4640.2003.tb02712.x","volume":"24","author":"PMG Bouloux","year":"2003","unstructured":"Bouloux PMG, Nieschlag E, Burger HG, Skakkebaek NE, Wu FCW, Handelsman DJ. Induction of spermatogenesis by recombinant follicle-stimulating hormone (Puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl. 2003;24:604\u201311.","journal-title":"J Androl"},{"key":"232_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","volume":"21","author":"Corifollitropin alfa Ensure Study Group","year":"2010","unstructured":"Corifollitropin alfa Ensure Study Group. Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reprod Biomed Online. 2010;21:66\u201376.","journal-title":"Reprod Biomed Online"},{"key":"232_CR8","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","volume":"24","author":"P Devroey","year":"2009","unstructured":"Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod. 2009;24:3063\u201372. Corrigendum: Hum Reprod. 2014;29:1116\u201320.","journal-title":"Hum Reprod"},{"key":"232_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fertnstert.2015.04.018","volume":"104","author":"R Boostanfar","year":"2015","unstructured":"Boostanfar R, Shapiro B, Levy M, Rosenwaks Z, Witjes H, Stegmann BJ, et al. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization. Fertil Steril. 2015;104:94\u2013103.","journal-title":"Fertil Steril"},{"key":"232_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","volume":"15","author":"BCJM Fauser","year":"2009","unstructured":"Fauser BCJM, Mannaerts BMJL, Devroey P, Leader A, Boime I, Baird DT. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update. 2009;15:309\u201321.","journal-title":"Hum Reprod Update"},{"key":"232_CR11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/humrep\/16.8.1592","volume":"16","author":"PMG Bouloux","year":"2001","unstructured":"Bouloux PMG, Handelsman DJ, Jockenh\u00f6vel F, Nieschlag E, Rabinovici J, Frasa WLH. First human exposure to FSH-CTP in hypogonadotropic hypogonadal males. Hum Reprod. 2001;16:1592\u20137.","journal-title":"Hum Reprod"},{"key":"232_CR12","unstructured":"WHO Laboratory Manual for the Examination and Processing of Human Sperm, 5th edition. Geneva: World Health Organisation; 2010."},{"key":"232_CR13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/12.5.980","volume":"12","author":"S Burgu\u00e9s","year":"1997","unstructured":"Burgu\u00e9s S, Calder\u00f3n MD, the Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Hum Reprod. 1997;12:980\u20136.","journal-title":"Hum Reprod"},{"key":"232_CR14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0015-0282(98)00156-3","volume":"70","author":"European Metrodin HP Study Group","year":"1998","unstructured":"European Metrodin HP Study Group. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil Steril. 1998;70:256\u201362.","journal-title":"Fertil Steril"},{"key":"232_CR15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/14.6.1540","volume":"14","author":"PY Liu","year":"1999","unstructured":"Liu PY, Turner L, Rushford D, McDonald J, Gordon Baker HW, Conway AJ, et al. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum Reprod. 1999;14:1540\u20135.","journal-title":"Hum Reprod"},{"key":"232_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cen.13164","volume":"86","author":"J Rohayem","year":"2017","unstructured":"Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M, German Adolescent Hypogonadotropic Hypogonadism Study Group. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotrophic hypogonadism? A multicentre prospective study of hCG\/rFSH treatment outcomes during adolescence. Clin Endocrinol (Oxf). 2017;86:75\u201387.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"232_CR17","doi-asserted-by":"crossref","unstructured":"Rocchietti March M, Isidori A. New frontiers in the treatment of male sterility. Contraception. 2002;65:279\u201381.","DOI":"10.1016\/S0010-7824(02)00296-2"},{"key":"232_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/andr.12128","volume":"4","author":"J Rohayem","year":"2016","unstructured":"Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology. 2016;4:87\u201394.","journal-title":"Andrology"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-017-0232-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:04:56Z","timestamp":1498377896000},"score":1,"resource":{"primary":{"URL":"http:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-017-0232-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1186\/s12958-017-0232-y","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]},"article-number":"17"}}